Search results :

VACV

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J05AB11

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Cough Cough 46% - 57% 46% x x x
Cough increased 6% - 10% x
Oedema peripheral Oedema peripheral 8% - 62% 9% - 62% x x x
Stomatitis Mouth ulceration 23% 23% x x x
Mouth ulceration Mouth ulceration 23% 23% x x x
Chest pain Chest pain 21% x x x
Oedema Oedema 4% - 54% 5% - 54% x x x
Sleep disorder Sleep disorder 15% - 21% 15% x x x
Infection Infection 2% - 16% 1% x x x
Headache Headache postmarketing — 2% - 62% 3% - 62% x x x x x x x x x x x x x x
Hypertension Hypertension postmarketing, 11% - 38% 8% - 38% x x x x x x x x x x x x
Myalgia Myalgia 0.5% - 57% 2.5% - 46% x x x
Musculoskeletal discomfort Myalgia 0.5% - 57% 2.5% - 46% x x x
Arthralgia 0% - 6% 0% - 6% x x x x x x x x x x x x
Body temperature increased Body temperature increased 1.4% - 11% 11% x x x x
Nausea Nausea postmarketing — 1% - 23% 2% - 23% x x x x x x x x x x x x x x
Sinusitis Sinusitis 7% x
Bronchitis Bronchitis 3% - 7% x
Anorectal disorder Rectal disorder 4% - 5% x
Hallucination Hallucination postmarketing — 8% 1% x x x x x x x x
Diarrhoea Diarrhoea postmarketing — 1% - 23% 0% - 23% x x x x x x x x x x x x x x
Injury Accidental injury 3% - 5% x
Dysmenorrhoea Dysmenorrhoea 1% - 8% 1% - 4% x x x x x x x
Somnolence Somnolence 0.9% - 23% 23% x x x
Abdominal pain Abdominal pain 1% - 12% 0% - 11% x x x x x x x x x x x x
Gastrointestinal pain Abdominal pain 1% - 12% 0% - 11% x x x x x x x x x x x x
Decreased appetite Anorexia 0.5% - 3% 2% x x x x x x
Asthenia Asthenia 0% - 43% 1% - 15% x x x x x x
Fatigue x x x x x
Dehydration Dehydration 2% x
Dizziness Dizziness postmarketing — 1% - 31% 0% - 31% x x x x x x x x x x x x x x
Herpes simplex Herpes simplex 2% x
Pharyngitis Pharyngitis 1% - 13% 1% x x x
Rhinitis Rhinitis 1.3% - 14% 1.5% - 2% x x x
Tooth disorder Tooth disorder 1% - 3% x
Vomiting Vomiting postmarketing — 1% - 8% 0% - 7% x x x x x x x x x x x x x x
Insomnia Insomnia 0% - 21% 0% - 15% x x x x x x
Nasopharyngitis Rhinorrhoea 2% x
Nasopharyngitis x x x x x
Rhinorrhoea Rhinorrhoea 2% x
Pain Pain 1% - 43% 1% - 31% x x x x x x
Constipation Constipation 1% - 21% 0% - 15% x x x x x x
Chills Chills 1% - 1.6% x x x
Back pain Back pain 0.5% - 29% 2% - 15% x x x
Depression Depression 0% - 21% 0% - 15% x x x x x x x
Dyspepsia Dyspepsia 0% - 4% 0% - 2% x x x x x x
Flatulence Flatulence 0% - 1.8% 0% x x x x x x
Anaemia Anaemia 0% - 12% 0% - 12% x x x x
Leukopenia Leukopenia very rare — 0.6% - 8% 0.2% - 8% x x x x x x x x x
Dyspnoea Dyspnoea postmarketing — 7% - 38% 5% - 38% x x x x x x x x x x x x x x
Dermatitis Rash postmarketing — 1% - 14% 0% - 1% x x x x x x x x x x x x x x
Rash Rash postmarketing — 1% - 14% 0% - 1% x x x x x x x x x x x x x x
Arthralgia Arthralgia 0% - 6% 0% - 6% x x x x x x x x x x x x
Eczema Eczema 0% - 1% 0% - 1% x x x
Influenza Influenza 0% - 7% 0% - 1% x x x x
Nervousness Nervousness 0% - 1% x x x
Tension Nervousness 0% - 1% x x x
Paraesthesia Paraesthesia 0% - 1% 0% - 1% x x x
Pruritus Pruritus postmarketing — 0% - 5% 0% - 2% x x x x x x x x x x x x x x
Dry mouth Dry mouth 0% - 3% 0% - 1% x x x x x x
Migraine Migraine 1% 1% x x x x
Acne Acne 1% 0% x x x x
Aggression Aggression postmarketing x x x x x x x x x
Alopecia Alopecia postmarketing x x x x x
Anaphylactic shock Anaphylactic shock very rare — rare x x x x x x x x x x x x x x
Aplastic anaemia Aplastic anaemia postmarketing x x x x x x x x x
Angioedema Angioedema very rare, postmarketing x x x x x x x x x x x x x x
Ataxia Ataxia very rare, postmarketing x x x x x x x x x x x x x
Coma Coma very rare, postmarketing x x x x x x x x x x x x x x
Confusional state Confusional state postmarketing — 7% 2% x x x x x x x x x x x x x x
Feeling abnormal Confusional state postmarketing — 7% 2% x x x x x x x x x x x x x x
Dysarthria Dysarthria very rare, postmarketing x x x x x x x x x x x x
Osteoarthritis Dysarthria very rare, postmarketing x x x x x x x x x x x x
Erythema multiforme Erythema multiforme postmarketing x x x x x x x x x
Haemolytic uraemic syndrome Haemolytic uraemic syndrome postmarketing x x x x x x x x
Hepatitis Hepatitis very rare — rare x x x x x x x x x x x x x x
Hypersensitivity Hypersensitivity postmarketing x x x x x x x x x x x
Immune system disorder Immune system disorder postmarketing x x x x x
Mediastinal disorder Mediastinal disorder postmarketing x x x x x
Nervous system disorder Nervous system disorder postmarketing x x x
Psychotic disorder Psychotic disorder very rare, postmarketing x x x x x x x x x x x x x x
Thrombotic thrombocytopenic purpura Thrombotic thrombocytopenic purpura postmarketing x x x x x x x x
Renal failure Renal failure very rare, postmarketing x x x x x x x x x x x x x x
Renal impairment postmarketing, rare x x x x x
Convulsion Convulsion very rare, postmarketing x x x x x x x x x x x x x
Tachycardia Tachycardia postmarketing x x x x x x x x x
Thrombocytopenia Thrombocytopenia very rare — 0.1% - 5% 0.7% - 5% x x x x x x x x x x x x x x
Tremor Tremor very rare — 4% 6% x x x x x x x x x x x x x
Urticaria Urticaria very rare, postmarketing x x x x x x x x x x x x x x
Immunodeficiency Immunocompromised very rare, postmarketing x x x x x
Encephalopathy Encephalopathy very rare, postmarketing x x x x x x x x x x x x x x
Agitation Agitation very rare, postmarketing x x x x x x x x x x x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x
Microangiopathic haemolytic anaemia Microangiopathic haemolytic anaemia postmarketing x x x x x x x x
Abdominal discomfort Abdominal discomfort postmarketing, rare x x x x x x x x
Neurological symptom Neurologic reaction postmarketing x x x x x x x x
Blood creatinine increased Blood creatinine increased postmarketing x x x
Creatinine increased x
Hepatobiliary disease Hepatobiliary disease postmarketing x x x
Mania Mania postmarketing x x x x x x
Photosensitivity reaction Photosensitivity postmarketing, uncommon x x x x x x x x x x x x x x
Menorrhagia Prolonged menses postmarketing x x x x x x x x
Face oedema Face oedema postmarketing x x x x x x x x x
Altered state of consciousness Depressed level of consciousness postmarketing, rare x x x x x x x x x x x x x
Depressed level of consciousness Depressed level of consciousness postmarketing, rare x x x x x x x x x x x x x
Renal pain Renal pain very rare, postmarketing x x x x x x x x x x x x x
Hallucinations, mixed Auditory and visual hallucinations postmarketing x x x x x x
Renal impairment Renal impairment postmarketing, rare x x x x x
Leukocytoclastic vasculitis Leukocytoclastic vasculitis postmarketing x x x x x x x x
Urethral disorder Urinary tract disorder very rare, postmarketing x x x
Urinary tract disorder Urinary tract disorder very rare, postmarketing x x x
Liver function test abnormal Raised liver function tests very rare — rare x x x x x
Thrombotic microangiopathy Thrombotic microangiopathy very rare, postmarketing x x x
Renal failure acute Renal failure acute very rare, postmarketing x x x x x x x x x x x x x
Cytomegalovirus infection Cytomegalovirus infection x
Fatigue Fatigue x x x x x
Gastrointestinal disorder Gastrointestinal disorder x x
Haematuria Haematuria x
Upper respiratory tract infection Upper respiratory tract infection x x x x x
Urinary tract infection Urinary tract infection x
Blood alkaline phosphatase increased Phosphatase alkaline increased x x x x x
Aspartate aminotransferase increased Aspartate aminotransferase increased x x x x x
Alanine aminotransferase increased Alanine aminotransferase increased x x x x x
Platelet count decreased Platelet count decreased x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

VALACYCLOVIR HYDROCHLORIDE / VALTREX

Side effects:37
Source:FDA

valacyclovir

Side effects:49
Source:FDA Structured Product Label

VALACYCLOVIR

Side effects:50
Source:FDA Structured Product Label

VALACYCLOVIR

Side effects:50
Source:FDA Structured Product Label

VALACYCLOVIR

Side effects:50
Source:FDA Structured Product Label

VALACYCLOVIR

Side effects:54
Source:FDA Structured Product Label

VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) / VALTREX

Side effects:61
Source:Health Canada

VALTREX Tablets / Valtrex, Film coated tablet

Side effects:44
Source:Medsafe

valaciclovir hydrochloride / VALVALA

Side effects:70
Source:medicines.org.au

Valaciclovir hydrochloride / Vaclovir

Side effects:72
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label